Physician profile
Michael Flaherty
NPI 1275792483
$31,478.28
in general payments reported to CMS, 2019-2025
9 companies · $4,268 in 2025
The $4,268 reported for 2025 was more than what 79% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,638 · 2020: $7,368 · 2021: $2,902 · 2022: $6,260 · 2023: $1,740 · 2024: $1,302 · 2025: $4,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,899 · Food and Beverage: $3,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,898.75 |
| Food and Beverage | $3,411.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $19,159.77 | 2019-2025 | |
| Arthrex, INC. | $8,983.36 | 2019-2025 | |
| Smith+Nephew, INC. | $1,099.88 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,042.33 | 2019-2023 | Comprehensive Shoulder System, Xtrafix, Biowick X |
| Arcuro Medical INC | $808.90 | 2025 | Superball |
| Miach Orthopaedics, INC. | $176.67 | 2025 | |
| Depuy Synthes Sales INC. | $80.05 | 2021-2024 | Inhance |
| Pacira Pharmaceuticals Incorporated | $64.02 | 2023 | Iovera, Zilretta, Exparel |
| Stryker Corporation | $63.30 | 2023 | Inspace, Axsos, Variax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Flaherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.